Peter Ellis - McMaster Experts

Affiliations

Faculty of Health Sciences, McMaster University
Associate Member, Escarpment Cancer Research Institute (ECRI), Faculty of Health Sciences
Professor, Oncology, Faculty of Health Sciences

Scholarly Activity in McMaster Experts

Co-author Network

Scholarly Activity
Research
Contact
View All

selected scholarly activity

chapters
- International enforcement of intellectual property: The approach of the English courts. 571-606. 2014
- Lung Carcinoma Surveillance Counterpoint: Canada. 83-92. 2013
- Chemotherapy for recurrent or refractory advanced non-small cell lung cancer. 669-682. 2012
- How to Enhance Development and Collaboration in Surgical Research. 695-714. 2010
- MEASURING ORGANIZATIONAL EFFICIENCY WITH DATA ENVELOPMENT ANALYSIS: THE HORACE MANN INSURANCE COMPANY. Applications of Management Science. 3-11. 2006
- ANOREXIA NERVOSA IN THE MALE: CLINICAL FEATURES AND FOLLOW-UP OF NINE PATIENTS. 315-321. 1986
conferences
- 114TiP KEYNOTE-B99: Phase II study of pembrolizumab plus investigational agents combined with chemotherapy as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC). Annals of Oncology. S1425-S1425. 2021
- Bradycardia associated with ALK inhibitors in the treatment of non-small cell lung cancers: a systematic review and meta-analysis. European Heart Journal. 2848-2848. 2021
- The Mutational Landscape of Human Somatic and Germline Cells.. Environmental and Molecular Mutagenesis. 51-52. 2021
- Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis. Journal of Thoracic Oncology. S506-S507. 2021
- A Tool for Modeling Energy and Resilience for Community-Scale Networks of Buildings and District Systems. ASHRAE Transactions. 3-11. 2021
- Cardiac Morbidity Following Radical Thoracic Chemoradiotherapy for Locally Advanced Lung Cancer: A Population-Based Cohort Study. International Journal of Radiation Oncology Biology Physics. e115-e116. 2020
- Randomized Phase II Trial of Metformin in Combination with Chemoradiotherapy (CRT) in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC); the OCOG-ALMERA trial (NCT02115464). International Journal of Radiation Oncology Biology Physics. S104-S104. 2020
- CARDIAC MORBIDITY FOLLOWING RADICAL THORACIC CHEMORADIOTHERAPY FOR LOCALLY ADVANCED LUNG CANCER: A POPULATION-BASED COHORT STUDY. Radiotherapy and Oncology. S90-S90. 2020
- A Comparison of Radiation Techniques in Patients Treated With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer. International Journal of Radiation Oncology Biology Physics. 985-992. 2020
- Real-world outcomes for metastatic non-small cell lung cancer patients treated with checkpoint inhibitor immunotherapy in Canada. Journal of Clinical Oncology. 2020
- Real-world outcomes for metastatic non-small cell lung cancer patients treated with checkpoint inhibitor immunotherapy in Canada.. Journal of Clinical Oncology. 54-54. 2020
- Almond snack consumption improves endothelial function in adults with moderate risk of cardiovascular disease: a randomised, controlled, parallel trial. Proceedings of the Nutrition Society. E636-E636. 2020
- Radiotherapy instead of inguinofemoral lymphadenectomy in vulvar cancer patients with a metastatic sentinel node: results of GROINSS-V II. International Journal of Gynecological Cancer. A14-A14. 2019
- Abstract # 3231 Telomerase-dependent senescence and inflammation with ageing in the zebrafish brain. Brain, Behavior, and Immunity. 7-7. 2019
- Complementary medicine (CM) use in phase III clinical trials (P3T) conducted by the Canadian Cancer Trials Group (CCTG). Annals of Oncology. 720-720. 2019
- MA11.04 Platinum Doublet + Durvalumab +/- Tremelimumab in Patients with Advanced NSCLC: A CCTG Phase IB Study - IND.226. Journal of Thoracic Oncology. S291-S292. 2019
- Pharmacokinetic (PK) and updated survival data from the Canadian cancer trials group IND.226 study of durvalumab ± tremelimumab in combination with platinum-doublet chemotherapy. Annals of Oncology. v179-v179. 2019
- Pharmacokinetic (PK) and updated survival data from the Canadian cancer trials group IND226 study of durvalumab +/- tremelimumab in combination with platinum-doublet chemotherapy. Annals of Oncology. 2019
- A Comparison of Radiation Techniques in Patients Treated with Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer. International Journal of Radiation Oncology Biology Physics. E526-E527. 2019
- A dose-finding study of the SMAC mimetic Debio 1143 when given in combination with avelumab to patients with advanced solid malignancies.. Journal of Clinical Oncology. 2599-2599. 2019
- Cost disparities with age in the treatment of advanced non-small cell lung cancer (NSCLC) in Ontario, Canada.. Journal of Clinical Oncology. 6629-6629. 2019
- The effect of age on referral to an oncologist and receipt of chemotherapy among small cell lung cancer patients in Ontario, Canada. Journal of Geriatric Oncology. 449-458. 2019
- Assessment of myocardial injury early after initiation of treatment in breast cancer patients using the Beckman Coulter and Abbott Diagnostics high-sensitivity cardiac troponin I tests. Clinical Biochemistry. 56-57. 2018
- MTE03.01 Inclusion/Exclusion Updates (CNS Mets, Multiple Prior Cancers, Organ Dysfunction). Journal of Thoracic Oncology. S208-S209. 2018
- P2.15-31 The Evolution of Costs in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Ontario, Canada Between 1999 to 2014. Journal of Thoracic Oncology. S829-S830. 2018
- Evaluation of the safety of continuing trastuzumab despite overt left ventricular dysfunction.. Journal of Clinical Oncology. e18548-e18548. 2018
- Evidence Driven Cancer Drug Approvals In Phase II Versus Phase III Clinical Trials Within A Single-Payer Public Healthcare System. Value in Health. S42-S42. 2018
- 69P The diabetes drug canagliflozin sensitizes non-small cell lung cancer (NSCLC) to radiotherapy and chemotherapy. Journal of Thoracic Oncology. S37-S37. 2018
- PREVENTING AND MANAGING THE LIFE-THREATENING GASTROINTESTINAL EFFECTS OF CLOZAPINE. Australian and New Zealand Journal of Psychiatry. 45-45. 2018
- Abstract P5-20-17: Safety of continuing chemotherapy in overt left ventricular dysfunction using antibodies to human epidermal growth factor receptor-2: A retrospective study. Cancer Research. p5-20-17-p5-20-17. 2018
- Safety of continuing chemotherapy in overt left ventricular dysfunction using antibodies to human epidermal growth factor receptor-2: A retrospective study. Cancer Research. 2018
- Model Like a Programmer 2: More Tools and Techniques for Greater Productivity. 2018 BUILDING PERFORMANCE ANALYSIS CONFERENCE AND SIMBUILD. 304-311. 2018
- SCRIPTING FRAMEWORKS FOR ENHANCING ENERGYPLUS MODELING PRODUCTIVITY. 2018 BUILDING PERFORMANCE ANALYSIS CONFERENCE AND SIMBUILD. 312-319. 2018
- MA 10.01 Durvalumab ± Tremelimumab with Platinum-Doublets in Non-Small Cell Lung Cancer: Canadian Cancer Trials Group Study IND.226. Journal of Thoracic Oncology. S1839-S1839. 2017
- A Phase 3, Multicenter, Randomized Trial to Evaluate the Symptomatic and Quality of Life Improvements in Lung Cancer Patients Receiving External Beam Radiation With or Without High Dose Rate Intraluminal Brachytherapy. International Journal of Radiation Oncology Biology Physics. S116-S116. 2017
- Costs of dacomitinib versus placebo in pretreated unselected patients (pts) with advanced NSCLC: CCTG BR.26. Annals of Oncology. 2017
- A meta-analysis of trials of etoposide plus platinum agent versus irinotecan/topotecan plus platinum agent in first-line therapy of extensive stage small cell lung cancer (ES SCLC).. Journal of Clinical Oncology. e20019-e20019. 2017
- Immune related adverse events (irAE) with platinum chemotherapy (CT) with durvalumab (D) ± tremelimumab (T): CCTG IND226.. Journal of Clinical Oncology. 3058-3058. 2017
- Abstract P1-12-10: Safety and efficacy of trastuzumab emtansine (T-DM1) in 399 patients with central nervous system metastases: Exploratory subgroup analysis from the KAMILLA study. Cancer Research. 2017
- Abstract S6-01: BRCA1 methylation status, silencing and treatment effect in the TNT trial: A randomized phase III trial of carboplatin compared with docetaxel for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer (CRUK/07/012). Cancer Research. 2017
- MA09.03 Cisplatin/Pemetrexed + Durvalumab +/- Tremelimumab in Pts with Advanced Non-Squamous NSCLC: A CCTG Phase IB Study - IND.226. Journal of Thoracic Oncology. S392-S393. 2017
- P1.07-050 Patterns of Relapse in Small Cell Lung Cancer (SCLC): A Retrospective Analysis of Outcomes from a Single Canadian Center. Journal of Thoracic Oncology. S727-S728. 2017
- A Canadian Cancer Trials Group phase IB study of durvalumab with or without tremelimumab + standard platinum-doublet chemotherapy in patients with advanced, incurable solid malignancies (IND.226). European Journal of Cancer. S95-S95. 2016
- Nurses Attitudes and Practices About Patient Activation And Self-Management Support in Cancer Care. Cancer Nursing. S58-S59. 2016
- OCOG-ALMERA: A phase II trial investigating the ability of metformin to chemo-radio-sensitize and prevent recurrence in locally advanced (LA) non-small cell lung cancer (NSCLC)∗. Journal of Thoracic Oncology. S50-S51. 2016
- Survival in Patients With Brain Metastases From Non-Small Cell Lung Cancer Treated in the Radiosurgery Era. International Journal of Radiation Oncology Biology Physics. E434-E435. 2015
- Chemoradiotherapy versus Radiotherapy Alone in Elderly Patients with Stage III Non-Small Cell Lung Cancer: A Systematic Review. Journal of Thoracic Oncology. S286-S286. 2015
- Comparative Survival in Patients with Brain Metastases from Non-Small Cell Lung Cancer Treated before and after Implementation of Radiosurgery. Journal of Thoracic Oncology. S276-S276. 2015
- A phase Ib study of selumetinib in patients (pts) with previously untreated metastatic Non-Small Cell Lung Cancer (NSCLC) receiving standard chemotherapy: NCIC Clinical Trials Group IND.215. NCT01783197.. Journal of Clinical Oncology. 2015
- A phase Ib study of selumetinib in patients (pts) with previously untreated metastatic Non-Small Cell Lung Cancer (NSCLC) receiving standard chemotherapy: NCIC Clinical Trials Group IND.215. NCT01783197.. Journal of Clinical Oncology. 8046-8046. 2015
- Amylase gene CNV and carbohydrate digestion - A postprandial metabolic study. Annals of Nutrition and Metabolism. 284-284. 2015
- Assessment of galectin-3, N-terminal pro-brain natriuretic peptide and inflammatory cytokines in patients with myocardial injury after initiation of adjuvant trastuzumab therapy. Clinical Biochemistry. 1144-1144. 2014
- Androgen pathway manipulation and outcome in elderly men with non-small cell lung cancer: A population-based study from Ontario, Canada.. Journal of Clinical Oncology. e17662-e17662. 2014
- Do patients with small cell lung cancer (SCLC) who have chemotherapy initiated during a hospital admission benefit from therapy?. Journal of Clinical Oncology. e17661-e17661. 2014
- NCIC CTG BR.26: A phase III randomized, double blind, placebo controlled trial of dacomitinib versus placebo in patients with advanced/metastatic non-small cell lung cancer (NSCLC) who received prior chemotherapy and an EGFR TKI.. Journal of Clinical Oncology. 8036-8036. 2014
- QUALITY OF HYPERTENSION CARE IN A STUDENT-RUN FREE CLINIC: A PILOT STUDY. Journal of General Internal Medicine. S188-S189. 2014
- Abstract P5-01-01: Lymphoid tissue inducer cells: Identification of a novel immune cell within the breast tumour microenvironment and its role in promoting tumour cell invasion. Cancer Research. 2013
- Abstract P6-06-03: Differing patterns of treatment effect in a trial assessing sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT). Cancer Research. 2013
- A RANDOMISED, OPEN-LABEL PHASE II TRIAL OF VOLASERTIB AS MONOTHERAPY AND IN COMBINATION WITH STANDARD DOSE PEMETREXED COMPARED WITH PEMETREXED MONOTHERAPY IN SECOND-LINE NON-SMALL CELL LUNG CANCER (NSCLC). Journal of Thoracic Oncology. S1200-S1200. 2013
- APPROACH TO BIOMARKER TESTING: PERSPECTIVES FROM VARIOUS SPECIALTIES. Journal of Thoracic Oncology. S1086-S1086. 2013
- ASSESSMENT OF HEALTH CARE PATTERNS FOR ELDERLY LUNG CANCER PATIENTS IN ONTARIO, CANADA. Journal of Thoracic Oncology. S403-S403. 2013
- CLINICAL IMPACT OF EGFR MUTATION FRACTION AND TUMOUR CELLULARITY IN EGFR MUTATION POSITIVE NSCLC. Journal of Thoracic Oncology. S1209-S1210. 2013
- EDUCATING COMMUNITY HEALTH PROFESSIONALS ABOUT LUNG CANCER: A PILOT EVALUATION OF A WEB-BASED EDUCATIONAL TOOL. Journal of Thoracic Oncology. S873-S874. 2013
- RESOURCE UTILIZATION IN THE LAST THREE MONTHS OF LIFE BY LUNG CANCER PATIENTS IN THE HAMILTON-NIAGARA-HALDIMAND-BRANT LOCAL HEALTH INTEGRATION NETWORK (LHIN). Journal of Thoracic Oncology. S213-S213. 2013
- TECEMOTIDE (L-BLP25) IN UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER IN THE PHASE III START STUDY: FURTHER ENDPOINT AND EXPLORATORY BIOMARKER RESULTS. Journal of Thoracic Oncology. S135-S136. 2013
- Clinical impact of EGFR mutation fraction and tumor cellularity in EGFR mutation positive NSCLC.. Journal of Clinical Oncology. 2013
- Abstract P1-13-03: Mature analysis of UK Taxotere as Adjuvant Chemotherapy (TACT) trial (CRUK 01/001); effects of treatment and characterisation of patterns of breast cancer relapse.. Cancer Research. 2012
- Abstract P2-10-29: Time dependent breast cancer metastasis prediction using novel biological imaging, clinico-pathological and genomic data combined with Bayesian modeling to reduce over-fitting and improve on inter-cohort reproducibility.. Cancer Research. 2012
- Abstract P2-14-01: Fulvestrant vs exemestane for treatment of metastatic breast cancer in patients with acquired resistance to non-steroidal aromatase inhibitors – a meta-analysis of EFECT and SoFEA (CRUKE/03/021 & CRUK/09/007). Cancer Research. 2012
- Abstract S3-3: The UK TACT2 Trial: comparison of standard vs accelerated epirubicin in patients requiring chemotherapy for early breast cancer (EBC) (CRUK/05/019). Cancer Research. 2012
- LONG-TERM EFFICACY AND SAFETY OF L-BLP25 VACCINE IN A MULTI-CENTRE OPEN-LABEL STUDY OF PATIENTS WITH UNRESECTABLE STAGE III NSCLC. Annals of Oncology. 395-395. 2012
- A randomized double-blind trial of carboplatin plus paclitaxel (CP) with daily oral cediranib (CED), an inhibitor of vascular endothelial growth factor receptors, or placebo (PLA) in patients (pts) with previously untreated advanced non-small cell lung cancer (NSCLC): NCIC Clinical Trials Group study BR29. Journal of Clinical Oncology. 2012
- NCIC IND.190: A phase I trial of MK-0646 in combination with cisplatin and etoposide in extensive-stage small cell lung cancer (ES SCLC).. Journal of Clinical Oncology. 2012
- Stage III NSCLC: How many patients are really suitable for radical treatment approaches?. Journal of Clinical Oncology. 2012
- Stage III NSCLC: How many patients are really suitable for radical treatment approaches?. Journal of Clinical Oncology. 2012
- Fulvestrant Alone or with Concomitant Anastrozole Vs Exemestane Following Progression On Non-steroidal Aromatase Inhibitor - First Results of the SoFEa Trial (CRUKE/03/021 & CRUK/09/007) (ISRCTN44195747). European Journal of Cancer. S2-S2. 2012
- Extremely Low Energy Design for Army Buildings: Barracks. ASHRAE Transactions. 767-789. 2012
- OT1-02-13: Cardiac Biomarkers on Trastuzumab (Cabot Trial): Determining the Cardiac Biomarker Profile in Breast Cancer Patients Receiving Adjuvant Trastuzumab Therapy.. Cancer Research. 2011
- A FUNCTIONAL GENOMICS APPROACH TO THE IDENTIFICATION OF BR :MARKERS OF SURVIVAL IN SEVERE SEPSIS DUE TO COMMUNITY ACQUIRED PNEUMONIA. Intensive Care Medicine. S200-S200. 2011
- GLOBAL GENE EXPRESSION PROFILING REVEALS KEY PATHWAYS ASSOCIATED WITH THE HOST RESPONSE TO CARDIAC SURGERY AND CARDIOPULMONARY BYPASS. Intensive Care Medicine. S12-S12. 2011
- DO BETA-BLOCKERS ALTER DYSPNEA AND FATIGUE IN ADVANCED LUNG CANCER? A RETROSPECTIVE ANALYSIS. Journal of Thoracic Oncology. S1192-S1193. 2011
- IMPLEMENTATION OF A NATIONAL EGFR TESTING STRATEGY IN A PUBLICLY FUNDED HEALTH SYSTEM. Journal of Thoracic Oncology. S1513-S1513. 2011
- COMBINING PROTEIN INTERACTION AND GENE PROFILING METHODS FOR PREDICTING LAPATINIB RESPONSE. Annals of Oncology. 43-43. 2011
- PMD19 COST-EFFECTIVENESS OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION TESTING IN THE SELECTION OF FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER IN ONTARIO. Value in Health. A82-A82. 2011
- THE METABOLIC SYNDROME IN OBESE PATIENTS WITH BINGE EATING DISORDER IN PRIMARY CARE CLINICS. Journal of General Internal Medicine. S25-S26. 2011
- A Phase I Study of Pomalidamide (CC-4047) in Combination With Cisplatin and Etoposide in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC). Journal of Thoracic Oncology. S551-S551. 2010
- 412 BMS-754807, an oral dual IGF-1R/insulin receptor (IR) inhibitor: initial results from a Phase 1 dose- and schedule-finding study in combination with carboplatin/paclitaxel in subjects with solid tumors. European Journal of Cancer, Supplement. 131-131. 2010
- A SYSTEMATIC REVIEW AND CONSENSUS RECOMMENDATIONS ON THE USE OF BIOMARKERS IN THE TREATMENT OF NON-SMALL CELL LUNG CARCINOMA (NSCLC). Annals of Oncology. 131-131. 2010
- A CONDITIONAL KNOCK-IN ALLELE OF THE TYPE A CYTOPLASMIC NUCLEOPHOSMIN MUTATION COOPERATES WITH A NOVEL SLEEPING BEAUTY TRANSPOSON TO CAUSE ACUTE MYELOID LEUKAEMIA IN MICE. Haematologica. 240-241. 2010
- Individualized patient care: Are we ready to meet the challenges for patients with lung cancer?. Journal of Clinical Oncology. e18121-e18121. 2010
- Microtubule Associated Protein Tau Expression as a Predictive and Prognostic Marker in a Trial Assessing Sequential Docetaxel as Adjuvant Chemotherapy for Early Breast Cancer (TACT).. Cancer Research. 523S-523S. 2009
- 87 DEVELOPING CONSENSUS AMONG CLINICAL EXPERTS AND NONEXPERTS FOR THE ROLE OF POSITRON EMISSION TOMOGRAPHY IN SMALL CELL LUNG CANCER. Radiotherapy and Oncology. S28-S28. 2009
- Evaluation of the deliverability and tolerability of intensive weekly doublet adjuvant chemotherapy in Non Small Cell Lung Cancer. Journal of Thoracic Oncology. S787-S787. 2009
- P.1.i.02l Neuroendocrine and psychological factors in chronic fatigue syndrome. European Neuropsychopharmacology. S348-S348. 2009
- Positron emission tomography in small cell lung cancer: a systematic review and practice guideline in Ontario, Canada. Journal of Thoracic Oncology. S462-S462. 2009
- Priority health needs for patients receiving concurrent chemotherapy and radiation for stage III non-small cell lung cancer and impact of the role of the advanced practice nurse (APN). Journal of Thoracic Oncology. S436-S437. 2009
- Strength in numbers - bringing lung cancer patients together through an information fair. Journal of Thoracic Oncology. S873-S873. 2009
- Survival of patients with non small cell lung cancer (NSCLC) following diagnosis of brain metastases. Journal of Thoracic Oncology. S543-S544. 2009
- The 4th Annual Ontario Thoracic Cancer Conference at Niagara-on-the-Lake. Current Oncology. 111-119. 2009
- Treatment and outcome of patients with brain metastases from non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 2009
- NOVEL OPTICAL PROTEOMICS MOLECULARLY PROFILES BREAST CANCER PATIENTS LEADING TO INDIVIDUALISED PROGNOSIS AND TAILORED TREATMENT. Annals of Oncology. 46-46. 2009
- Modelling the cost-effectiveness of first, second and third generation polychemotherapy regimens in women with early breast cancer who have differing prognoses. Cancer Research. 379S-379S. 2009
- Safety of surgery in patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC) treated with docetaxel (D) plus bevacizurnab (BV) or placebo (PL) in the AVADO phase III study. Cancer Research. 115S-115S. 2009
- MANIPULATION OF LIPID BIOACCESSIBILITY INFLUENCES POSTPRANDIAL GUT HORMONE RESPONSES IN HEALTH HUMAN SUBJECTS. Annals of Nutrition and Metabolism. 584-584. 2009
- Monocyte gene expression profiling in individuals with contrasting familial risk for premature myocardial infarction. Heart. A61-A62. 2008
- A multicenter, open-label, phase I/II study in patients with unresectable stage III non-small cell lung cancer (NSCLC) treated with L-BLP25: 2-year survival and safety results. Journal of Clinical Oncology. 3047-3047. 2008
- A phase I dose escalation trial of BI 2536, a novel Plk1 inhibitor, with standard dose pemetrexed in previously treated advanced or metastatic non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 8115-8115. 2008
- Pharmacokinetic (PK) analysis of a phase I trial investigating continuous treatment with the angiokinase inhibitor BIBF 1120 combined with pemetrexed in previously treated patients with non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 14511-14511. 2008
- Manipulation of lipid bioaccessibility of almonds influences postprandial lipemia in healthy human subjects. The FASEB Journal. 2008
- The 3rd Annual Ontario Thoracic Cancer Conference at Niagara-on-the-Lake. Current Oncology. 155-161. 2008
- Randomized Phase II Study of Gemcitabine Plus Cisplatin or Carboplatin, With or Without Cetuximab, As First-Line Therapy for Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 5777-5784. 2007
- B1-01: A multi-centre phase IIB randomized controlled study of BLP25 liposome vaccine (L-BLP25 or Stimuvax) for active specific immunotherapy of non-small cell lung cancer (NSCLC): updated survival analysis. Journal of Thoracic Oncology. S332-S333. 2007
- PD6-1-7: A phase II study of UCN-01 in combination with topotecan in patients (pts) with chemosensitive relapsed small cell lung cancer (SCLC): a study of the Princess Margaret Hospital phase II consortium (PMH-C).. Journal of Thoracic Oncology. S427-S427. 2007
- A multi-centre, open-label study to assess the safety of Stimuvax (BLP25 liposome vaccine or L-BLP25) in non-small cell lung cancer (NSCLC) patients (pts) with unresectable stage III disease. Journal of Clinical Oncology. 2007
- A randomized trial of computer and pamphlet-based versions of the Decision Board (DB). Journal of Clinical Oncology. 2007
- What can physicians do to promote patient involvement in decision making (DM) in the oncology consultation?. Journal of Clinical Oncology. 2007
- Meaning of hope and preferences for communicating hope in the prognosis in the metastatic cancer setting. Psycho-Oncology. S97-S97. 2006
- A comparison of patient and physician attributes that promote patient involvement in treatment decision making in the oncology consultation.. Journal of Clinical Oncology. 325S-325S. 2006
- Agreement between physicians and patients about what constitutes shared decision making.. Journal of Clinical Oncology. 316S-316S. 2006
- Delays in diagnosis and initiating treatment for patients with lung cancer.. Journal of Clinical Oncology. 326S-326S. 2006
- Understanding and preferences for receiving prognostic information: A comparison of the views of Australian and Canadian patients with metastatic cancer. Journal of Clinical Oncology. 304S-304S. 2006
- Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer. Journal of Clinical Oncology. 2038-2043. 2006
- Phase I study of daily oral AZD 2171, an inhibitor of the vascular endothelial growth factor receptor (VEGFR), in combination with carboplatin/paclitaxel in patients with advanced non-small cell lung cancer (NSCLC): A study of the NCICCTG.. Clinical Cancer Research. 8970S-8970S. 2005
- Randomized Phase IIB Trial of BLP25 Liposome Vaccine in Stage IIIB and IV Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 6674-6681. 2005
- Phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer (NSCLC). Lung Cancer. S256-S256. 2005
- Phase I/II study of GTI-2040 plus docetaxel as 2nd-line treatment in non-small cell lung cancer (NSCLC) and other solid tumors.. Journal of Clinical Oncology. 683S-683S. 2005
- Randomized, phase III trial comparing irinotecan/cisplatin (IP) with etoposide/cisplatin (EP) in patients (pts) with previously untreated, extensive-stage (ES) small cell lung cancer (SCLC).. Journal of Clinical Oncology. 1094S-1094S. 2005
- Randomized, phase III trial comparing irinotecan/cisplatin (IP) with etoposide/cisplatin (EP) in patients (pts) with previously untreated, extensive-stage (ES) small cell lung cancer (SCLC).. Journal of Clinical Oncology. 622S-622S. 2005
- S9900: A phase III trial of surgery alone or surgery plus preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): Preliminary results. Journal of Clinical Oncology. 624S-624S. 2005
- S9900: A phase III trial of surgery alone or surgery plus preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): Preliminary results.. Journal of Clinical Oncology. 1095S-1095S. 2005
- The effect of doxycycline on bone turnover and tumor markers in breast cancer (BC) patients with skeletal metastases. Journal of Clinical Oncology. 3198-3198. 2005
- The effect of doxycycline on bone turnover and tumor markers in breast cancer (BC) patients with skeletal metastases.. Journal of Clinical Oncology. 240S-240S. 2005
- The significance of textures for affective interfaces. Lecture Notes in Computer Science. 394-404. 2005
- Cancer patients and the Internet: A randomized controlled trial (RCT) evaluating an intervention to facilitate physician and patient information exchange from the Internet (I).. Journal of Clinical Oncology. 553S-553S. 2004
- Safety and efficacy of DHA-paclitaxel (TXP) in non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 644S-644S. 2004
- Characterization of SOX2-expressing neural progenitors in vitro and in vivo. Glia. 51-51. 2003
- Stromal proliferation of benign phyllodes tumours is driven by epithelial Wnt signalling, but Wnt-independence occurs during malignant progression. Journal of Pathology. 28A-28A. 2001
- Adjuvant taxanes for early breast cancer - Clinical uncertainty exists. British Journal of Cancer. 20-20. 2001
- The Wnt-APC-beta catenin pathway in phyllodes tumours. British Journal of Cancer. 20-20. 2001
- Repeatability and reliability of the tube suction test. Transportation Research Record. 151-157. 2001
- The effects of sildenafil citrate (Viagra (R)) on color discrimination in volunteers and patients with erectile dysfunction.. Investigative Ophthalmology and Visual Science. S693-S693. 1999
- Selected points from the discussion. International Congress and Symposium Series - Royal Society of Medicine. 67-72. 1999
- The effects of fibre on diabetes. International Congress and Symposium Series - Royal Society of Medicine. 33-42. 1999
- DIGIT-BEARING LUMBAR MASS WITH SPINAL DYSRAPHISM. Journal of Neuropathology and Experimental Neurology. 484-484. 1998
- Apoptotic index as a prognostic factor in a trial of primary medical therapy for carcinoma of the breast.. British Journal of Cancer. 11-11. 1998
- Construction of an optimally diverse portfolio. PROCEEDINGS OF THE TWENTY-SEVENTH ANNUAL MEETING OF THE WESTERN DECISION SCIENCES INSTITUTE. 162-164. 1998
- Efficiency comparison in commercial insurance lines. DECISION SCIENCES INSTITUTE 1998 PROCEEDINGS, VOLS 1-3. 154-156. 1998
- THE IN-VIVO PHARMACOLOGICAL PROFILE OF CP-122,288, A SELECTIVE INHIBITOR OF NEUROGENIC INFLAMMATION. British Journal of Pharmacology. P7-P7. 1995
- THE AIRLINE CONTRIBUTION TO NOISE REDUCTION. EURO NOISE '92, PROCEEDINGS, BOOKS 1-3. 137-151. 1992
- A COMBINATION OF TRADITIONAL CYTOGENETIC TECHNIQUES AND INSITU HYBRIDIZATION HAS ALLOWED ELUCIDATION OF THE KARYOTYPE IN 2 YOUNG BOYS WITH ABNORMAL SEX-CHROMOSOME COMPLEMENTS. American Journal of Human Genetics. 264-264. 1991
- ANALYSIS OF THE OPTIMAL COMPETITION LINEUP IN NCAA INTERCOLLEGIATE WOMENS GYMNASTICS. PROCEEDINGS OF THE TWENTIETH ANNUAL MEETING OF THE WESTERN DECISION SCIENCE INSTITUTE, LIHUE, KAUAI, HAWAII, MARCH 19-22, 1991. 773-775. 1991
- Down's syndrome in the Lothian region of Scotland — 1978 to 1989. Biomedicine and Pharmacotherapy. 267-272. 1991
- ECONOMIES OF SCALE IN THE FEDERAL-DEPOSIT-INSURANCE-CORPORATION. PROCEEDINGS OF THE TWENTIETH ANNUAL MEETING OF THE WESTERN DECISION SCIENCE INSTITUTE, LIHUE, KAUAI, HAWAII, MARCH 19-22, 1991. 169-173. 1991
- SYNOVIAL-FLUID PROTEIN-CONCENTRATION IN PATIENTS UNDERGOING TEMPOROMANDIBULAR-JOINT ARTHROSCOPY. Journal of Dental Research. 296-296. 1990
- BENEFICIAL HEMODYNAMIC PROFILE OF UK-61,260 IN AN ANESTHETIZED DOG HEART-FAILURE MODEL. British Journal of Pharmacology. P695-P695. 1988
- DIVERSITY OF JURASSIC AND LOWER CRETACEOUS CARBONATE SEQUENCES IN THE LUSITANIAN BASIN OF PORTUGAL - MODELS FOR EXPLORATION IN THE MEDITERRANEAN AND ATLANTIC. American Association of Petroleum Geologists Bulletin. 1000-1000. 1988
- SEISMIC AND SEDIMENTOLOGIC FEATURES OF KIMMERIDGIAN SYN-RIFT SILICICLASTIC AND CARBONATE SLOPE DEPOSITS OF THE LUSITANIAN BASIN, PORTUGAL. American Association of Petroleum Geologists Bulletin. 999-1000. 1988
- CARBONATE BUILDUP DEVELOPMENT WITHIN A PASSIVE-MARGIN SETTING - UPPER JURASSIC OF LUSITANIAN BASIN, PORTUGAL, AND COMPARABLE CARBONATES FROM EASTERN NORTH-AMERICAN SEABOARD. American Association of Petroleum Geologists Bulletin. 553-553. 1987
- THE SCOTTISH-CHILDRENS-TUMOUR-REGISTER - CLINICAL, PATHOLOGICAL AND CYTOGENETIC CONSIDERATIONS. Clinical Genetics. 303-304. 1985
- YTS - THE TRAINEES (AND OTHERS) TALK BACK. Bulletin of the British Psychological Society. A47-A47. 1985
- A SATELLITED CHROMOSOME-2. Journal of Medical Genetics. 54-54. 1984
- ANTENATAL DIAGNOSIS AND ITS RELATION TO CHROMOSOME ABNORMALITY IN THE PERINATAL-PERIOD - CYTOGENETIC AND PATHOLOGIC CONSIDERATIONS. Laboratory Investigation. P3-P3. 1984
- VIEWS OF CATERING - CAREERS AND PERSONNEL APPLICATIONS OF AN ATTITUDE SURVEY. Bulletin of the British Psychological Society. A77-A78. 1983
- NEPHRO-BLASTOMA AND THE 11P- CHROMOSOME. Journal of Medical Genetics. 63-63. 1982
- DENOVO TRANSLOCATIONS IN A SELECTED POPULATION. Journal of Medical Genetics. 220-220. 1981
- FAMILY STUDIES FOLLOWING CYTOGENETIC ANALYSIS OF EARLY SPONTANEOUS-ABORTIONS. Clinical Genetics. 501-501. 1981
- A GENETIC-LINKAGE STUDY OF HUNTINGTONS-CHOREA. Cytogenetic and Genome Research. 163-163. 1979
- TOWARDS A THEORETICAL-MODEL FOR STUDYING MANS RELATIONS WITH PHYSICAL-ENVIRONMENT. Bulletin of the British Psychological Society. 27-27. 1978
- Psychological adjustment to cancer: A preliminary report of a randomised controlled trial of cognitive behavioural therapy and interpersonal psychotherapy. Psycho-Oncology. S33-S33.
designs
- 'DEATH' 1978
- 'SPRING AGAIN' 1978
journal articles
- Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy.. Radiation Oncology. 19:155. 2024
- Implementation of Liquid Biopsy in Non-Small-Cell Lung Cancer: An Ontario Perspective.. Current Oncology. 31:6017-6031. 2024
- Biopsychosocial Associates of Psychological Distress and Post-Traumatic Growth among Canadian Cancer Patients during the COVID-19 Pandemic.. Current Oncology. 31:5354-5366. 2024
- Molecular Testing in Non–Small-Cell Lung Cancer: A Call to Action. JCO Oncology Practice. 20:7-9. 2024
- Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline. Journal of Clinical Oncology. 41:5448-5472. 2023
- Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non‐small cell lung cancer (NSCLC) through inhibition of HIF‐1α. Molecular Oncology. 17:2235-2256. 2023
- Update on the Management of Stage III NSCLC: Navigating a Complex and Heterogeneous Stage of Disease. Current Oncology. 30:9514-9529. 2023
- Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on Trastuzumab. Oncologist. 28:e712-e722. 2023
- Evaluating Oncology Clinical Pathways: What Bar Are We Aiming for?. JCO Oncology Practice. 19:692-693. 2023
- Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies. JACC: CardioOncology. 5:415-430. 2023
- Detection of Macrotroponin in Patients Receiving Treatment for Breast Cancer. CJC OPEN. 5:658-660. 2023
- BRACHY: A Randomized Trial to Evaluate Symptom Improvement in Advanced Non-Small Cell Lung Cancer Treated With External Beam Radiation With or Without High-Dose-Rate Intraluminal Brachytherapy. International Journal of Radiation Oncology Biology Physics. 116:601-610. 2023
- Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer. Current Oncology. 30:6289-6315. 2023
- A phase II study of durvalumab re-treatment +/- prednisone in patients who discontinued prior checkpoint therapy due to immune related toxicity (CCTG IND.238A).. Journal of Clinical Oncology. 41:TPS2673-TPS2673. 2023
- Author Correction: Reliable detection of somatic mutations in solid tissues by laser-capture microdissection and low-input DNA sequencing. Nature Protocols. 18:1979-1979. 2023
- Use of antibiotics and outcomes of patients presenting to emergency department with non-neutropenic fever and/or suspected infection.. Journal of Clinical Oncology. 41:e18693-e18693. 2023
- Surgical, Radiation, and Systemic Treatments of Patients With Thymic Epithelial Tumors: A Systematic Review. Journal of Thoracic Oncology. 18:299-312. 2023
- Cardiac Morbidity Following Chemoradiation in Stage III Non-small Cell Lung Cancer Patients: A Population-Based Cohort Study. Clinical Oncology. 35:e182-e188. 2023
- Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis. Current Oncology. 29:9046-9065. 2022
- Surgical, Radiation, and Systemic Treatments of Patients With Thymic Epithelial Tumors: A Clinical Practice Guideline. Journal of Thoracic Oncology. 17:1258-1275. 2022
- Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline. Journal of Clinical Oncology. 40:3310-3322. 2022
- Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline. Journal of Clinical Oncology. 40:3323-3343. 2022
- Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials. Oncologist. 27:e286-e293. 2022
- ALK inhibitor-induced bradycardia: A systematic-review and meta-analysis. Lung Cancer. 161:9-17. 2021
- Pertuzumab Cardiotoxicity in Patients With HER2-Positive Cancer: A Systematic Review and Meta-analysis. CJC OPEN. 3:1372-1382. 2021
- The mutational landscape of human somatic and germline cells. Nature. 597:381-386. 2021
- Metformin in Combination With Chemoradiotherapy in Locally Advanced Non–Small Cell Lung Cancer. JAMA Oncology. 7:1333-1333. 2021
- Patterns of Relapse in Small Cell Lung Cancer: Competing Risks of Thoracic versus CNS Relapse. Current Oncology. 28:2778-2788. 2021
- Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study. Clinical Cancer Research. 27:3884-3895. 2021
- High-throughput full-length single-cell RNA-seq automation. Nature Protocols. 16:2886-2915. 2021
- Somatic mutation landscapes at single-molecule resolution. Nature. 593:405-410. 2021
- Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update. Journal of Clinical Oncology. 39:1040-1091. 2021
- P48.18 Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis. Journal of Thoracic Oncology. 16:S506-S507. 2021
- Reliable detection of somatic mutations in solid tissues by laser-capture microdissection and low-input DNA sequencing. Nature Protocols. 16:841-871. 2021
- A Canadian cancer trials group phase IB study of durvalumab (anti-PD-L1) plus tremelimumab (anti-CTLA-4) given concurrently or sequentially in patients with advanced, incurable solid malignancies. Investigational New Drugs. 38:1442-1447. 2020
- Occupational risk prevention, education and support in black, Asian and ethnic minority health worker in the COVID-19 pandemic. Journal of Patient Safety and Risk Management. 25:205-209. 2020
- 212: Cardiac Morbidity Following Radical Thoracic Chemoradiotherapy for Locally Advanced Lung Cancer: A Population-Based Cohort Study. Radiotherapy and Oncology. 150:S90-S90. 2020
- Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update. Journal of Clinical Oncology. 38:1608-1632. 2020
- A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226. Lung Cancer. 143:1-11. 2020
- The mutational landscape of normal human endometrial epithelium. Nature. 580:640-646. 2020
- Value assessment of oncology drugs using a weighted criterion‐based approach. Cancer. 126:1530-1540. 2020
- Immunotherapy with check-point inhibitors (CPI) in adult malignancies: a protocol for the systematic review of the quality of economic analyses. Systematic Reviews. 8:139. 2019
- Adjuvant Trastuzumab Therapy: Can We Balance Efficacy and Safety?. Oncologist. 24:1405-1409. 2019
- 122 A Comparison of Radiation Techniques in Patients Treated with Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer. Radiotherapy and Oncology. 139:S53-S53. 2019
- Complementary medicine (CM) use in phase III clinical trials (P3T) conducted by the Canadian Cancer Trials Group (CCTG). Annals of Oncology. 30:v720-v720. 2019
- Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity. JACC: CardioOncology. 1:1-10. 2019
- A Phase I Study of Pomalidomide (CC-4047) in Combination with Cisplatin and Etoposide in Patients with Extensive-Stage Small-Cell Lung Cancer (vol 8, pg 423, 2013). Journal of Thoracic Oncology. 14:1484-1484. 2019
- A post-hoc subgroup analysis assessing acute cardiac biomarker profiles in female cancer patients during adjuvant therapy. Clinica Chimica Acta. 495:355-357. 2019
- An Evaluation of the Safety of Continuing Trastuzumab Despite Overt Left Ventricular Dysfunction. Current Oncology. 26:240-246. 2019
- Resource Use in the Last Three Months of Life by Lung Cancer Patients in Southern Ontario. Current Oncology. 26:247-252. 2019
- Initial Management of Small-Cell Lung Cancer (limited- and Extensive-Stage) and the Role of Thoracic Radiotherapy and First-Line Chemotherapy: A Systematic Review. Current Oncology. 26:372-384. 2019
- Surgery after Chemoradiotherapy in Patients with Stage III (n2 or N3, Excluding T4) Non-Small-Cell Lung Cancer: A Systematic Review. Current Oncology. 26:398-404. 2019
- Steroid receptor coactivator-1 modulates the function of Pomc neurons and energy homeostasis. Nature Communications. 10:1718. 2019
- Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials. The Lancet. 393:1440-1452. 2019
- Longitudinal High-Sensitivity Cardiac Troponin I Measurements in Patients With Breast Cancer Receiving Trastuzumab. Canadian Journal of Cardiology. 35:545.e1-545.e2. 2019
- A lentiviral vector‐based insertional mutagenesis screen identifies mechanisms of resistance to MAPK inhibitors in melanoma. Pigment Cell and Melanoma Research. 32:332-335. 2019
- Methods to improve the estimation of time‐to‐event outcomes when data is de‐identified. Statistics in Medicine. 38:625-635. 2019
- Guideline for the Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-line Chemotherapy. Clinical Oncology. 30:658-666. 2018
- Antiangiogenic Therapies in Non-Small-Cell Lung Cancer. Current Oncology. 25:45-58. 2018
- Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. The Lancet Oncology. 19:27-39. 2018
- Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 13:e0209486-e0209486. 2018
- Case for Stopping Targeted Therapy When Lung Cancer Progresses on Treatment in Hospice-Eligible Patients. JCO Oncology Practice. 13:780-783. 2017
- Non-visualized aorta in abdominal aortic aneurysm screening: Screening outcomes and the influence of subject and programme characteristics. Journal of Medical Screening. 24:214-219. 2017
- EGFR mutation positive non-small cell lung cancer: can we identify predictors of benefit from immune checkpoint inhibitors. ANNALS OF TRANSLATIONAL MEDICINE. 5:424-424. 2017
- Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology. 35:3484-3515. 2017
- Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update. Journal of Clinical Oncology. 35:2960-2974. 2017
- Costs of dacomitinib versus placebo in pretreated unselected patients (pts) with advanced NSCLC: CCTG BR.26. Annals of Oncology. 28:v398-v398. 2017
- Immune Checkpoint Inhibitors for Patients With Advanced Non–Small-Cell Lung Cancer: A Systematic Review. Clinical Lung Cancer. 18:444-459.e1. 2017
- Endovascular treatment for ruptured abdominal aortic aneurysm. Cochrane Database of Systematic Reviews. 2017:CD005261. 2017
- Evaluation of stored liquid biopsies for molecular profiling in patients with non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 35:9024-9024. 2017
- Postoperative Adjuvant Systemic Therapy in Completely Resected Non–Small-Cell Lung Cancer: A Systematic Review. Clinical Lung Cancer. 18:259-273.e8. 2017
- Comparative Survival in Patients with Brain Metastases from Non-small-Cell Lung Cancer Treated before and after Implementation of Radiosurgery. Current Oncology. 24:146-151. 2017
- Radiotherapy With Curative Intent in Patients With Early-stage, Medically Inoperable, Non–Small-cell Lung Cancer: A Systematic Review. Clinical Lung Cancer. 18:105-121.e5. 2017
- Guideline for Radiotherapy with Curative Intent in Patients with Early-Stage Medically Inoperable Non-Small-Cell Lung Cancer. Current Oncology. 24:44-49. 2017
- In memoriam/À la mémoire de. Canadian Journal of Plant Pathology. 39:1-4. 2017
- Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage Disease. Clinical Lung Cancer. 18:68-76.e2. 2017
- Spatiotemporal Mapping Techniques Show Clozapine Impairs Neurogenic and Myogenic Patterns of Activity in the Colon of the Rabbit in a Dose-Dependent Manner. Frontiers in Pharmacology. 8:209. 2017
- The Porirua Protocol in the Treatment of Clozapine-Induced Gastrointestinal Hypomotility and Constipation: A Pre- and Post-Treatment Study. CNS Drugs. 31:75-85. 2017
- Assessment of Referral and Chemotherapy Treatment Patterns for Elderly Patients With Non–small-Cell Lung Cancer. Clinical Lung Cancer. 17:563-572.e2. 2016
- Biomarker guided treatment of advanced non-small cell lung cancer: does feasibility translate to improvements in patient care?. Translational Cancer Research. 5:S1181-S1184. 2016
- Chemoradiotherapy versus radiotherapy alone in elderly patients with stage III non-small cell lung cancer: A systematic review and meta-analysis. Lung Cancer. 99:180-185. 2016
- Second-Line Treatment of Non-Small Cell Lung Cancer: New Developments for Tumours Not Harbouring Targetable Oncogenic Driver Mutations. Drugs. 76:1321-1336. 2016
- The Use of Systemic Treatment in the Maintenance of Patients with Non–Small Cell Lung Cancer: A Systematic Review. Journal of Thoracic Oncology. 11:989-1002. 2016
- Approach to Biomarker Testing: Perspectives from Various Specialties. Current Oncology. 23:178-183. 2016
- Reasons for Frequent Emergency Department Use by Medicaid Enrollees: A Qualitative Study. Academic Emergency Medicine. 23:476-481. 2016
- Clinical impact of mutation fraction in epidermal growth factor receptor mutation positive NSCLC patients. British Journal of Cancer. 114:616-622. 2016
- Clozapine-treated Patients Have Marked Gastrointestinal Hypomotility, the Probable Basis of Life-threatening Gastrointestinal Complications: A Cross Sectional Study. EBioMedicine. 5:125-134. 2016
- Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non–Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. Journal of Thoracic Oncology. 11:312-323. 2016
- A Free, Open-Source Tool for Identifying Urban Agglomerations using Point Data. Spatial Economic Analysis. 11:67-91. 2016
- Anti-angiogenesis in Personalized Therapy of Lung Cancer. Advances in Experimental Medicine and Biology. 893:91-126. 2016
- A Randomized, Open-Label Phase II Trial of Volasertib as Monotherapy and in Combination With Standard-Dose Pemetrexed Compared With Pemetrexed Monotherapy in Second-Line Treatment for Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 16:457-465. 2015
- The Receptor for the CD200 Tolerance‐Signaling Molecule Associated with Successful Pregnancy is Expressed by Early‐Stage Breast Cancer Cells in 80% of Patients and by Term Placental Trophoblasts. Early pregnancy : biology and medicine : the official journal of the Society for the Investigation of Early Pregnancy. 74:387-391. 2015
- Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology. 33:3488-3515. 2015
- Diagnosing Lung Cancer in the 21st Century: Are We Ready to Meet the Challenge of Individualized Care?. Current Oncology. 22:272-278. 2015
- Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib, Erlotinib, Afatinib, Dacomitinib, and Icotinib in the Treatment of Non-Small-Cell Lung Cancer: A Systematic Review. Current Oncology. 22:183-215. 2015
- Anti-angiogenic therapy in advanced non-small cell lung carcinoma (NSCLC): is there a role in subsequent lines of therapy?. Journal of Thoracic Disease. 7:214-216. 2015
- A mixed methods approach to understand variation in lung cancer practice and the role of guidelines. Implementation Science. 9:36. 2014
- Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial. The Lancet Oncology. 15:1379-1388. 2014
- The CD200-tolerance Signaling Molecule Associated with Pregnancy Success is Present In Patients with Early-stage Breast Cancer but Does not Favor Nodal Metastasis. Early pregnancy : biology and medicine : the official journal of the Society for the Investigation of Early Pregnancy. 72:435-439. 2014
- Minimally invasive thoracic surgery for early stage non-small cell lung cancer. The BMJ. 349:g5849-g5849. 2014
- Pooled Analysis of the Prognostic and Predictive Value of Kras Mutation Status and Mutation Subtype in Patients with Non-Small Cell Lung Cancer (Nsclc) Treated with Egfr Tkis (E-Tki). Annals of Oncology. 25:iv58-iv58. 2014
- The Relationship Between Egfr and Kras Mutation Status and Overall Survival (Os) in the Ncic Ctg Br.26 Randomized Trial of Dacomitinib (D) Versus Placebo (P) in Patients with Previously Treated Non Small Cell Lung Cancer (Nsclc). Annals of Oncology. 25:iv462-iv462. 2014
- Urbanization for Everyone: Benefits of Urbanization in Indonesia’s Rural Regions. Journal of the Urban Planning and Development Division, ASCE. 140. 2014
- Endovascular treatment for ruptured abdominal aortic aneurysm. Clinical Respiratory Journal. CD005261. 2014
- Brain Metastases in Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 15:249-257. 2014
- Stage III Non–Small-Cell Lung Cancer: Establishing a Benchmark for the Proportion of Patients Suitable for Radical Treatment. Clinical Lung Cancer. 15:274-280. 2014
- Successful Management of Latent Tuberculosis Infection in an Underserved Community by a Student-run Free Clinic. Journal of Health Care for the Poor and Underserved. 25:837-862. 2014
- Selective nuclear export of specific classes of mRNA from mammalian nuclei is promoted by GANP. Nucleic Acids Research (NAR). 42:5059-5071. 2014
- NCIC CTG IND.190 Phase I Trial of Dalotuzumab (MK-0646) in Combination with Cisplatin and Etoposide in Extensive-Stage Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9:410-413. 2014
- Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29. European Journal of Cancer. 50:706-712. 2014
- Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial. The Lancet Oncology. 15:59-68. 2014
- The Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly: An Evidence-Based Approach. Frontiers in Oncology. 4:178. 2014
- Treatment Paradigms for Patients with Metastatic Non-Small Cell Lung Cancer, Squamous Lung Cancer: First, Second, and Third-Line. Frontiers in Oncology. 4:157. 2014
- Physician‐related facilitators and barriers to patient involvement in treatment decision making in early stage breast cancer: perspectives of physicians and patients. Health Expectations. 16:373-384. 2013
- Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood. 122:3616-3627. 2013
- Listening is paramount when discussing sensitive topics with patients. The BMJ. 347:f5746-f5746. 2013
- Challenges to Implementation of an Epidermal Growth Factor Receptor Testing Strategy for Non–Small-Cell Lung Cancer in a Publicly Funded Health Care System. Journal of Thoracic Oncology. 8:1136-1141. 2013
- Understanding the Needs of Colorectal Cancer Patients during the Pre-diagnosis Phase. Journal of Cancer Education. 28:402-407. 2013
- Survival of Patients with Non-Small-Cell Lung Cancer after a Diagnosis of Brain Metastases. Current Oncology. 20:300-306. 2013
- Antabuse's diamond anniversary: Still sparkling on?. Drug and Alcohol Review. 32:342-344. 2013
- A case of ‘cryptogenic’ type D carotid cavernous fistula presenting initially with Cluster-like headache. Clinical Neurology and Neurosurgery. 115:1144-1146. 2013
- A Comparison of Patient Knowledge of Clinical Trials and Trialist Priorities. Current Oncology. 20:193-205. 2013
- Women’s perceptions of their involvement in treatment decision making for early stage breast cancer. Supportive Care in Cancer. 21:1717-1723. 2013
- Clinical impact of EGFR mutation fraction and tumor cellularity in EGFR mutation positive NSCLC.. Journal of Clinical Oncology. 31:e19077-e19077. 2013
- Capacity of forensic patients to consent to treatment. Australian and New Zealand Journal of Psychiatry. 47:443-450. 2013
- A Phase I Study of Pomalidomide (CC-4047) in Combination with Cisplatin and Etoposide in Patients with Extensive-Stage Small-Cell Lung Cancer. Journal of Thoracic Oncology. 8:423-428. 2013
- Recovery of evidence‐based practice. International Journal of Mental Health Nursing. 22:3-14. 2013
- A Phase I Open-Label Dose-Escalation Study of Intravenous BI 2536 Together With Pemetrexed in Previously Treated Patients With Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 14:19-27. 2013
- Cardiac and Inflammation Biomarker Profile after Initiation of Adjuvant Trastuzumab Therapy. Clinical Chemistry. 59:327-329. 2013
- Improving Quality of Preventive Care at a Student-Run Free Clinic. PLoS ONE. 8:e81441-e81441. 2013
- Improving Referral of Patients for Consideration of Adjuvant Chemotherapy after Surgical Resection of Lung Cancer. Current Oncology. 19:422-427. 2012
- A Population Study of Childhood Maltreatment and Asthma Diagnosis. Psychosomatic Medicine. 74:817-823. 2012
- Multitargeted anti-angiogenic agents and NSCLC: Clinical update and future directions. Critical Reviews in Oncology/Hematology. 84:47-58. 2012
- Challenges in Implementing Personalized Medicine for Lung Cancer within a National Healthcare System. Journal of Personalized Medicine. 2:77-92. 2012
- Do beta-blockers alter dyspnea and fatigue in advanced lung cancer? A retrospective analysis. Palliative Medicine. 26:797-803. 2012
- Gene Expression Profiles in White Blood Cells of Volunteers Exposed to a 50 Hz Electromagnetic Field. Radiation Research. 178:138-138. 2012
- Long-Term Efficacy and Safety of L-BLP25 Vaccine in a Multi-Centre Open-Label Study of Patients with Unresectable Stage III NSCLC. Annals of Oncology. 23:ix395-ix395. 2012
- The Importance of Multidisciplinary Team Management of Patients with Non-Small-Cell Lung Cancer. Current Oncology. 19:7-15. 2012
- Understanding the needs of lung cancer patients during the pre-diagnosis phase. Journal of Cancer Education. 27:494-500. 2012
- A randomized double-blind trial of carboplatin plus paclitaxel (CP) with daily oral cediranib (CED), an inhibitor of vascular endothelial growth factor receptors, or placebo (PLA) in patients (pts) with previously untreated advanced non-small cell lung cancer (NSCLC): NCIC Clinical Trials Group study BR29.. Journal of Clinical Oncology. 30:7511-7511. 2012
- NCIC IND.190: A phase I trial of MK-0646 in combination with cisplatin and etoposide in extensive-stage small cell lung cancer (ES SCLC).. Journal of Clinical Oncology. 30:7093-7093. 2012
- Stage III NSCLC: How many patients are really suitable for radical treatment approaches?. Journal of Clinical Oncology. 30:e17532-e17532. 2012
- KRAS Mutation Spectrum Notably Diverges between Non-small Cell Lung and Colorectal Carcinomas: In Response. Journal of Thoracic Oncology. 7:774-774. 2012
- Role of Pemetrexed in Sdvanced Non-Small-Cell Lung Cancer: Meta-Analysis of Randomized Controlled Trials, with Histology Subgroup Analysis. Current Oncology. 19:9-15. 2012
- What is the Quality of Preventive Care Provided in a Student-Run Free Clinic?. Journal of Health Care for the Poor and Underserved. 23:414-424. 2012
- SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts. New England Journal of Medicine. 365:1384-1395. 2011
- An Evidence-Based Approach to the Use of Predictive Biomarkers in the Treatment of Non- Small Cell Lung Cancer (NSCLC). Cancers. 3:3506-3524. 2011
- Delays in the diagnosis of lung cancer.. Journal of Thoracic Disease. 3:183-188. 2011
- Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial. Journal of Cancer Research and Clinical Oncology. 137:1337-1342. 2011
- A Systematic Review and Canadian Consensus Recommendations on the Use of Biomarkers in the Treatment of Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 6:1379-1391. 2011
- Using bevacizumab to treat metastatic cancer: UK consensus guidelines. British journal of hospital medicine (London, England : 2005). 71:670-678. 2010
- A Multicenter Open-Label Study to Assess the Safety of a New Formulation of BLP25 Liposome Vaccine in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 11:391-395. 2010
- Payer and provider collaborations that improve quality outcomes in oncology.. Managed care (Langhorne, Pa.). 19:35-42. 2010
- Treatment-emergent hypertension and outcomes in patients with advanced non-small-cell lung cancer receiving chemotherapy with or without the vascular endothelial growth factor receptor inhibitor cediranib: NCIC Clinical Trials Group Study BR24. Annals of Oncology. 21:2220-2226. 2010
- Complex Exon-Intron Marking by Histone Modifications Is Not Determined Solely by Nucleosome Distribution. PLoS ONE. 5:e12339-e12339. 2010
- Noninvasive molecular imaging of apoptosis in vivo using a modified firefly luciferase substrate, Z-DEVD-aminoluciferin. Cell Death and Differentiation. 17:1003-1010. 2010
- Phase I Open-Label Study of Continuous Treatment with BIBF 1120, a Triple Angiokinase Inhibitor, and Pemetrexed in Pretreated Non–Small Cell Lung Cancer Patients. Clinical Cancer Research. 16:2881-2889. 2010
- First-Line Systemic Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer: A Systematic Review. Journal of Thoracic Oncology. 5:260-274. 2010
- Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study. Journal of Clinical Oncology. 28:49-55. 2010
- Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Medicine. 7:62. 2009
- Microarray-based cytogenetic profiling reveals recurrent and subtype-associated genomic copy number aberrations in feline sarcomas. Chromosome Research. 17:987-1000. 2009
- A Phase I/II Study of GTI-2040 Plus Docetaxel as Second-Line Treatment in Advanced Non-small Cell Lung Cancer: A Study of the PMH Phase II Consortium. Journal of Thoracic Oncology. 4:1163-1169. 2009
- ‘Putting our heads together’: insights into genomic conservation between human and canine intracranial tumors. Journal of Neuro-Oncology. 94:333-349. 2009
- Neonates harbour highly active γδ T cells with selective impairments in preterm infants. European Journal of Immunology. 39:1794-1806. 2009
- Tumor Cavitation: Impact on Objective Response Evaluation in Trials of Angiogenesis Inhibitors in Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 27:404-410. 2009
- Phase II Trial of OGX-011 in Combination with Docetaxel in Metastatic Breast Cancer. Clinical Cancer Research. 15:708-713. 2009
- The Role of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as Therapy for Advanced, Metastatic, and Recurrent Non-Small-Cell Lung Cancer: A Canadian National Consensus Statement. Current Oncology. 16:27-48. 2009
- Generation of a genomic tiling array of the human Major Histocompatibility Complex (MHC) and its application for DNA methylation analysis. BMC Medical Genomics. 1:19. 2008
- Women's perceptions of their treatment decision-making about breast cancer treatment. Patient Education and Counseling. 73:431-436. 2008
- Estimating the Prevalence of Schizophrenia Among New Zealand Māori: A Capture–Recapture Approach. Australian and New Zealand Journal of Psychiatry. 42:941-949. 2008
- Extraskeletal Ewing's Sarcoma/Primitive Neuroectodermal Tumor of the Posterior Mediastinum with t(11;22)(q24;q12). Tumori. 94:888-891. 2008
- The 3rd Annual Ontario Thoracic Cancer Conference at Niagara-on-the-Lake. Current Oncology. 15:155-161. 2008
- Life-Threatening Clozapine-Induced Gastrointestinal Hypomotility. Journal of Clinical Psychiatry. 69:759-768. 2008
- Lipomatous Lumbar Mass with an Attached Digit and Associated Split Cord Malformation. Canadian Journal of Neurological Sciences. 35:250-254. 2008
- Phase I and Pharmacokinetic Study of Daily Oral AZD2171, an Inhibitor of Vascular Endothelial Growth Factor Tyrosine Kinases, in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non–Small-Cell Lung Cancer: The National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology. 26:1871-1878. 2008
- European oncologists' preferences for the management of breast cancer: case presentations and expert commentary. Breast. 17:S1-S12. 2008
- A Novel CpG Island Set Identifies Tissue-Specific Methylation at Developmental Gene Loci. PLoS Biology. 6:e22-e22. 2008
- A genome assembly-integrated dog 1 Mb BAC microarray: a cytogenetic resource for canine cancer studies and comparative genomic analysis. Cytogenetic and Genome Research. 122:110-121. 2008
- Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non–Small-Cell Lung Cancer Guideline. Journal of Clinical Oncology. 25:5506-5518. 2007
- Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non–Small-Cell Lung Cancer Guideline. JCO Oncology Practice. 3:332-335. 2007
- Phase II Study of Vandetanib or Placebo in Small-Cell Lung Cancer Patients After Complete or Partial Response to Induction Chemotherapy With or Without Radiation Therapy: National Cancer Institute of Canada Clinical Trials Group Study BR.20. Journal of Clinical Oncology. 25:4278-4284. 2007
- P3-091: A Phase I study of continuous oral treatment with the triple angiokinase inhibitor BIBF 1120 together with pemetrexed in previously treated patients with non-small cell lung cancer. Journal of Thoracic Oncology. 2:S717-S718. 2007
- A multi-centre, open-label study to assess the safety of Stimuvax (BLP25 liposome vaccine or L-BLP25) in non-small cell lung cancer (NSCLC) patients (pts) with unresectable stage III disease. Journal of Clinical Oncology. 25:3075-3075. 2007
- A randomized trial of computer and pamphlet-based versions of the Decision Board (DB). Journal of Clinical Oncology. 25:6508-6508. 2007
- What can physicians do to promote patient involvement in decision making (DM) in the oncology consultation?. Journal of Clinical Oncology. 25:19553-19553. 2007
- Towards optimal endocrine therapy for hormone-sensitive breast cancer: Initial versus sequential adjuvant aromatase inhibition. Cancer Letters. 248:165-174. 2007
- Adjuvant vinorelbine plus cisplatin extended survival longer than observation in resected non–small-cell lung cancer at median 76 months. ACP journal club. 146:31-31. 2007
- Guidelines on the standards for the training of specialised health professionals dealing with breast cancer. European Journal of Cancer. 43:660-675. 2007
- Endovascular treatment for ruptured abdominal aortic aneurysm. Clinical Respiratory Journal. CD005261. 2007
- Whole-genome array-CGH for detection of submicroscopic chromosomal imbalances in children with mental retardation. Cytogenetic and Genome Research. 118:1-7. 2007
- A Phase I Evaluation of Oral CI-1033 in Combination with Paclitaxel and Carboplatin as First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 1:1010-1019. 2006
- A Phase I Evaluation of Oral CI-1033 in Combination with Paclitaxel and Carboplatin as First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 1:1010-1019. 2006
- Second-line or Subsequent Systemic Therapy for Recurrent or Progressive Non-Small Cell Lung Cancer: A Systematic Review and Practice Guideline. Journal of Thoracic Oncology. 1:1042-1058. 2006
- Second-line or Subsequent Systemic Therapy for Recurrent or Progressive Non-Small Cell Lung Cancer: A Systematic Review and Practice Guideline. Journal of Thoracic Oncology. 1:1042-1058. 2006
- The Use of Chemotherapy in Patients with Advanced Malignant Pleural Mesothelioma: A Systematic Review and Practice Guideline. Journal of Thoracic Oncology. 1:591-601. 2006
- A comparison of patient and physician attributes that promote patient involvement in treatment decision making in the oncology consultation. Journal of Clinical Oncology. 24:6098-6098. 2006
- Agreement between physicians and patients about what constitutes shared decision making. Journal of Clinical Oncology. 24:6065-6065. 2006
- Delays in diagnosis and initiating treatment for patients with lung cancer. Journal of Clinical Oncology. 24:6102-6102. 2006
- Final results of a phase I study of daily oral AZD2171, an inhibitor of vascular endothelial growth factor receptors (VEGFR), in combination with carboplatin (C) + paclitaxel (T) in patients with advanced non-small cell lung cancer (NSCLC): A study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG). Journal of Clinical Oncology. 24:3054-3054. 2006
- Understanding and preferences for receiving prognostic information: A comparison of the views of Australian and Canadian patients with metastatic cancer. Journal of Clinical Oncology. 24:6014-6014. 2006
- Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. The Lancet Oncology. 7:141-148. 2006
- Breast carcinoma during pregnancy. Cancer. 106:237-246. 2006
- Diffusion and dissemination of evidence-based dietary srategies for the prevention of cancer. Nutrition Journal. 4:130-140. 2005
- Directed differentiation of neural cells to hypothalamic dopaminergic neurons. Development. 132:5185-5197. 2005
- Taxanes as first-line therapy for advanced non-small cell lung cancer: A systematic review and practice guideline. Lung Cancer. 50:355-374. 2005
- A Systematic Review of Studies Evaluating Diffusion and Dissemination of Selected Cancer Control Interventions.. Health Psychology. 24:488-500. 2005
- Adjuvant trastuzumab for HER2-positive breast cancer. The Lancet. 366:634-634. 2005
- Communicating prognosis in cancer care: a systematic review of the literature. Annals of Oncology. 16:1005-1053. 2005
- Multiple risk behaviour and its association with head and neck injuries: a national analysis of young Canadians. Preventive Medicine. 41:240-246. 2005
- P-526 Phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer (NSCLC). Lung Cancer. 49:S255-S256. 2005
- Phase I/II study of GTI-2040 plus docetaxel as 2nd-line treatment in non-small cell lung cancer (NSCLC) and other solid tumors. Journal of Clinical Oncology. 23:7253-7253. 2005
- Randomized, phase III trial comparing irinotecan/cisplatin (IP) with etoposide/cisplatin (EP) in patients (pts) with previously untreated, extensive-stage (ES) small cell lung cancer (SCLC). Journal of Clinical Oncology. 23:LBA7004-LBA7004. 2005
- S9900: A phase III trial of surgery alone or surgery plus preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): Preliminary results. Journal of Clinical Oncology. 23:LBA7012-LBA7012. 2005
- Mental Disorders Among Maori Attending Their General Practitioner. Australian and New Zealand Journal of Psychiatry. 39:401-406. 2005
- Diffusion and dissemination of evidence-based dietary strategies for the prevention of cancer.. Current Oncology. 4:13. 2005
- Communicating With Realism and Hope: Incurable Cancer Patients' Views on the Disclosure of Prognosis. Journal of Clinical Oncology. 23:1278-1288. 2005
- A city initiative to improve the quality of life for urban youth: how evaluation contributed to effective social programming. Evaluation and Program Planning. 28:83-94. 2005
- Evidence-based guidelines: response to Professor Gordon Parker's critique. Australian and New Zealand Journal of Psychiatry. 38:891-895. 2004
- General practitioner recognition of mental illness in the absence of a 'gold standard'. Australian and New Zealand Journal of Psychiatry. 38:789-794. 2004
- Assessing outcomes of cancer care: Lessons to be learned from a retrospective review of the management of small cell lung cancer at the Cancer Therapy Centre, Liverpool Hospital, January 1996−July 2000. Journal of Medical Imaging and Radiation Oncology. 48:364-370. 2004
- Mesothelioma and a High Potassium. Journal of the Royal Society of Medicine. 97:390-390. 2004
- Mesothelioma and a high potassium. Journal of the Royal Society of Medicine. 97:390-390. 2004
- Cancer patients and the Internet: A randomized controlled trial (RCT) evaluating an intervention to facilitate physician and patient information exchange from the Internet (I). Journal of Clinical Oncology. 22:6139-6139. 2004
- Cancer patients and the Internet: A randomized controlled trial (RCT) evaluating an intervention to facilitate physician and patient information exchange from the Internet (I). Journal of Clinical Oncology. 22:6139-6139. 2004
- Seeking informed consent to cancer clinical trials:. Social Science and Medicine. 58:2445-2457. 2004
- Cancer Patient Preferences for Communication of Prognosis in the Metastatic Setting. Journal of Clinical Oncology. 22:1721-1730. 2004
- Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline. Lung Cancer. 44:1-11. 2004
- Practice guideline for the role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer. Lung Cancer. 43:223-240. 2004
- SOX2, a Persistent Marker for Multipotential Neural Stem Cells Derived from Embryonic Stem Cells, the Embryo or the Adult. Developmental Neuroscience. 26:148-165. 2004
- National Network of Libraries for Health. CANADIAN MEDICAL ASSOCIATION JOURNAL. 169:282-282. 2003
- SOX2 Functions to Maintain Neural Progenitor Identity. Neuron. 39:749-765. 2003
- β‐catenin abnormalities and associated insulin‐like growth factor overexpression are important in phyllodes tumours and fibroadenomas of the breast. Journal of Pathology. 200:627-632. 2003
- Phase II Study of the Efficacy and Tolerability of Two Dosing Regimens of the Farnesyl Transferase Inhibitor, R115777, in Advanced Breast Cancer. Journal of Clinical Oncology. 21:2492-2499. 2003
- A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer.. Cancer Research. 63:2610-2615. 2003
- Diffusion and dissemination of evidence-based cancer control interventions.. Evidence report/technology assessment (Summary). 1-5. 2003
- In reply: How long should drug treatment of depression last?. Medical Journal of Australia. 178:526-527. 2003
- Malignant phyllodes tumours show stromal overexpression of c‐myc and c‐kit. Journal of Pathology. 200:59-64. 2003
- Evidence for Equivalent Electrocardiographic Changes Among the 5-HT3 Receptor Antagonists. Oncologist. 8:216-218. 2003
- Review: cognitive therapy may be no more effective than other bona fide psychological therapies for depression. Evidence-Based Mental Health. 6:25-25. 2003
- Negotiating for Change. The Healthcare Manager as Catalyst for Evidence-Based Practice: Changing the Healthcare Environment and Sharing Experience. Healthcare Papers. 3:10-22. 2003
- Use of gemcitabine in non-small-cell lung cancer. Current Oncology. 10:3-26. 2003
- Factors that influence the recruitment of patients to Phase III studies in oncology. Cancer. 95:1584-1591. 2002
- Informing breast cancer patients about clinical trials:a randomized clinical trial of an educational booklet. Annals of Oncology. 13:1414-1423. 2002
- Symmetrical upper limb peromelia and lower limb phocomelia associated with a de novo apparently balanced reciprocal translocation: 46,XX,t(2;12)(p25.1;q24.1). Clinical Dysmorphology. 11:87-90. 2002
- The Wnt pathway, epithelial–stromal interactions, and malignant progression in phyllodes tumours. Journal of Pathology. 196:437-444. 2002
- Is aggressive lipid‐lowering therapy preferable to angioplasty in stable coronary artery disease?. Medical Journal of Australia. 175:492-493. 2001
- Cancer care: what are the priorities?. The Lancet Oncology. 2:636-641. 2001
- Randomized Clinical Trials in Oncology: Understanding and Attitudes Predict Willingness to Participate. Journal of Clinical Oncology. 19:3554-3561. 2001
- An Application of Delaware's Risk-Based Corrective Action Program: To a Site with MTBE Contamination. Journal of Soil Contamination. 10:405-421. 2001
- Advocacy for clinical trials: do the Royal Colleges and State cancer councils play an appropriate role?. Australian and New Zealand Journal of Public Health. 25:9-11. 2001
- Japanese Encephalitis. Veterinary Clinics of North America. Equine Practice. 16:565-578. 2000
- Attitudes towards and participation in randomised clinical trials in oncology: A review of the literature. Annals of Oncology. 11:939-946. 2000
- Molecular Analysis of Phyllodes Tumors Reveals Distinct Changes in the Epithelial and Stromal Components. American Journal of Pathology. 156:1093-1098. 2000
- Improving recruitment to cancer clinical trials. Cancer Forum. 23:153-155. 1999
- Student and faculty learning styles in a Canadian and a Chilean self-directed, problem-based nursing program.. Canadian Journal of Nursing Research. 31:31-50. 1999
- General practitioners' attitudes to randomised clinical trials for women with breast cancer. Medical Journal of Australia. 171:303-305. 1999
- Doctors' participation in randomized trials of adjuvant systemic therapy in breast cancer: how does it relate to their recommendations for standard therapy in breast cancer?. Breast. 8:182-187. 1999
- BARRIERS TO PARTICIPATION IN RANDOMIZED CLINICAL TRIALS FOR EARLY BREAST CANCER AMONG AUSTRALIAN CANCER SPECIALISTS. ANZ Journal of Surgery. 69:486-491. 1999
- Attitudes to randomized clinical trials amongst out‐patients attending a medical oncology clinic. Health Expectations. 2:33-43. 1999
- Clinical follow-up of high mid-trimester maternal serum intact human chorionic gonadotrophin concentrations in singleton pregnancies. Prenatal Diagnosis. 19:219-223. 1999
- How should doctors communicate the diagnosis of cancer to patients?. Annals of Medicine. 31:336-341. 1999
- Trends in prenatal diagnosis of Down syndrome and other autosomal trisomies in Scotland 1990 to 1994, with associated cytogenetic and epidemiological findings. Genetic Epidemiology. 16:179-190. 1999
- A FISH study of chromosome fusion in the ICF syndrome: involvement of paracentric heterochromatin but not of the centromeres themselves.. Journal of Medical Genetics. 35:833-835. 1998
- Focus group interviews examining attitudes to randomised trials among breast cancer patients and the general community. Australian and New Zealand Journal of Public Health. 22:528-531. 1998
- Ethics of randomized clinical trials.. Journal of Clinical Oncology. 16:2570. 1998
- Pegasus joins the jet age. Australian Veterinary Journal. 76:476-477. 1998
- Communication is a vital part of care. The BMJ. 316:1891-1892. 1998
- Ethical debate. Truth, the first casualty. Communication is a vital part of care.. The BMJ. 316:1891-1892. 1998
- Ethical debate: Truth, the first casualty Deadly charades Communication is a vital part of care Doctors and patients should be fellow travellers. The BMJ. 316:1890-1893. 1998
- Ventriculoperitoneal shunt knot: a rare cause of bowel obstruction and ischemia.. Canadian Journal of Surgery. 41:239-240. 1998
- Book Reviews. School Psychology International. 19:96-96. 1998
- Coping with cancer chemotherapy. Modern Medicine of Australia. 41:32-37. 1998
- Evidence of no difference or just no evidence of any difference. Internal Medicine Journal. 27:600-600. 1997
- Psychosis following Acute Alteration of Thyroid Status. Australian and New Zealand Journal of Psychiatry. 31:762-764. 1997
- OSTEOSARCOMA AND PULMONARY METASTASES: 15‐YEAR EXPERIENCE FROM A SINGLE INSTITUTION. ANZ Journal of Surgery. 67:625-629. 1997
- The occurrence of germ cell malignancies in two patients positive for HIV antibodies. International Journal of STD and AIDS. 8:526-527. 1997
- The status and distribution of the Red-throated DiverGavia stellatain Britain in 1994. Bird Study. 44:194-205. 1997
- 'Race' and community care - Ahmad,W, Atkin,K. Health and Social Care in the Community. 5:216-216. 1997
- Lead exposure in Latin America and the Caribbean. Lead Research Group of the Pan-American Health Organization.. Environmental Health Perspectives. 105:398-405. 1997
- Meeting patients' information needs beyond the year 2000. Supportive Care in Cancer. 5:85-89. 1997
- Dimeric Inhibins in Amniotic Fluid, Maternal Serum, and Fetal Serum in Human Pregnancy. Journal of Clinical Endocrinology and Metabolism (JCEM). 82:218-222. 1997
- Dimeric Inhibins in Amniotic Fluid, Maternal Serum, and Fetal Serum in Human Pregnancy¹. Journal of Clinical Endocrinology and Metabolism (JCEM). 82:218-222. 1997
- On the receiving end V: Patient perceptions of the side effects of cancer chemotherapy in 1993. Annals of Oncology. 7:189-195. 1996
- Impact of prenatal diagnosis on revised livebirth prevalence estimates of Down syndrome in the Lothian region of Scotland, 1978–1992. Genetic Epidemiology. 13:367-375. 1996
- Impact of prenatal diagnosis on revised livebirth prevalence estimates of Down syndrome in the Lothian region of Scotland, 1978–1992. Genetic Epidemiology. 13:367-375. 1996
- DISCONTINUATION OF ANTIHYPERLIPIDEMIC DRUGS. New England Journal of Medicine. 333:1082-1083. 1995
- ICF SYNDROME (IMMUNODEFICIENCY, CENTROMERIC INSTABILITY AND FACIAL ANOMALIES) - INVESTIGATION OF HETEROCHROMATIN ABNORMALITIES AND REVIEW OF CLINICAL OUTCOME. Human Genetics. 96:411-416. 1995
- Tamoxifen flare — an unusual case of hypercalcaemia and transient rapidly progressive pancytopenia. Internal Medicine Journal. 25:375-376. 1995
- AGE, RACE AND ETHNICITY - BLAKEMORE,K, BONEHAM,M. Health and Social Care in the Community. 3:133-136. 1995
- RACE AND HEALTH IN CONTEMPORARY BRITAIN - AHMAD,W. Health and Social Care in the Community. 3:133-136. 1995
- An Evaluation of Soil‐Gas Surveying for H₂S for Locating Subsurface Hydrocarbon Contamination. Ground Water Monitoring and Remediation. 15:124-132. 1995
- Prenatal diagnosis of fragile X syndrome: Management of the male fetus with a premutation. Prenatal Diagnosis. 14:469-474. 1994
- Current Issues in Cancer Management of carcinomas of the upper gastrointestinal tract. The BMJ. 308:834-838. 1994
- CRANIOCERVICAL FUSION WITH CONTOURED LUQUE ROD AND AUTOGENIC BONE-GRAFT. Canadian Journal of Surgery. 37:50-54. 1994
- On the Subject of a Divided Europe: A Preliminary Survey of a Sample of UK University Students. Psychological Reports. 73:1096-1098. 1993
- Cytogenetic Abnormalities in Childhood Acute Lymphoblastic Leukemia. International Journal of Pediatric Hematology/Oncology. 10:25-30. 1993
- Platelet ³H‐imipramine binding during recovery from depression. Acta Psychiatrica Scandinavica. 86:108-112. 1992
- Single photon emission tomography assessment of cerebral dopamine D2 receptor blockade in schizophrenia. Biological Psychiatry. 32:293-295. 1992
- RISKS WITH TRANSLOCATION IN TYPUS EDINBURGENSIS - REPLY. Pediatrics. 89:355-355. 1992
- Acute Lymphoblastic Leukemia and Klinefelter's Syndrome. International Journal of Pediatric Hematology/Oncology. 9:81-85. 1992
- EXCEPTIONALLY LOW BODY-WEIGHTS OF ARCTIC TERNS STERNA-PARADISAEA ON SHETLAND. Ibis. 134:87-88. 1992
- First‐trimester diagnosis of Hunter syndrome (MPS II). Prenatal Diagnosis. 12:72-73. 1992
- Reliability of the draft diagnostic criteria for research of ICD‐10 in comparison with ICD‐10 and DSM‐III‐R. Acta Psychiatrica Scandinavica. 84:332-335. 1991
- Clinical information in psychiatric practice: what do doctors know, what do they think is known and what do they record?. Medical Education. 25:438-443. 1991
- Platelet tritiated imipramine binding in patients suffering from mania. Journal of Affective Disorders. 22:105-110. 1991
- TYPUS-EDINBURGENSIS EXPLAINED. Pediatrics. 88:151-154. 1991
- CARE OF THE PATIENT WITH MS. Practitioner. 235:248-&. 1991
- Equine viral arteritis. Australian Veterinary Journal. 67:429-431. 1990
- The occurrence of equine arteritis virus in Australia. Australian Veterinary Journal. 67:432-435. 1990
- Breeding ecology of the MerlinFalco columbariusin Shetland. Bird Study. 37:101-110. 1990
- Relevance to prenatal diagnosis of the identification of a human Y/autosome translocation by Y‐chromosome‐specific in situ hybridisation. Molecular Reproduction and Development. 25:37-41. 1990
- ECSTASY ABUSE. New Zealand Medical Journal. 102:358-358. 1989
- AN ETIOLOGICAL STUDY OF ISOCHROMOSOME-X TURNERS SYNDROME. Clinical Genetics. 36:53-58. 1989
- 4 CASES FOUND AT SCREENING IN GENERAL-PRACTICE. Practitioner. 233:758-759. 1989
- Benzodiazepine Abuse and Management of Anxiety in the Community. Substance Use and Misuse. 23:1083-1090. 1988
- Peer review as an aid to improving the completeness of psychiatric case notes. Medical Education. 21:493-497. 1987
- TRAINING PRACTICE NURSES FOR PREVENTION. Journal of the Royal College of General Practitioners. 37:221-222. 1987
- PRESCRIBING HYPNOTIC BENZODIAZEPINES. The BMJ. 294:182-182. 1987
- FULL EXPRESSION OF HUNTERS DISEASE IN A FEMALE WITH AN X-CHROMOSOME DELETION LEADING TO NONRANDOM INACTIVATION. Clinical Genetics. 30:392-398. 1986
- CARITAS, QUALITY AND GENERAL-PRACTICE. Journal of the Royal College of General Practitioners. 36:428-429. 1986
- RELATIVE SUPPORT GROUPS. Journal of the Royal College of General Practitioners. 36:51-51. 1986
- Anorexia nervosa in the male: Clinical features and follow-up of nine patients. Journal of Psychiatric Research. 19:315-321. 1985
- PRESCRIBING AGAIN. Journal of the Royal College of General Practitioners. 35:585-585. 1985
- Research and Practice. Environment and Behavior. 17:119-132. 1985
- Using Bivalent Integer Programming to Select Teams for Intercollegiate Women's Gymnastics Competition. Interfaces. 14:41-46. 1984
- CYTOGENETICS IN THE EVALUATION OF PERINATAL DEATH. The Lancet. 1:630-631. 1984
- THE STATUS OF THE GOLDEN EAGLE IN BRITAIN. British Birds. 77:592-607. 1984
- Shortlisting trainees. The BMJ. 285:892-892. 1982
- INTERSTITIAL DELETION OF CHROMOSOME-7 - A CASE-REPORT AND REVIEW OF THE LITERATURE. Clinical Genetics. 22:256-265. 1982
- Too few vocational training schemes. The BMJ. 283:504-504. 1981
- CYTOGENETICS AND REPRODUCTION OF SHEEP WITH MULTIPLE CENTRIC FUSIONS (ROBERTSONIAN TRANSLOCATIONS). Reproduction. 57:363-+. 1979
- Optimum location of training centers. Omega. The International Journal of Management Science. 7:569-573. 1979
- SCIENTIFIC BASIS OF DENTAL-HEALTH EDUCATION. British Dental Journal. 147:292-292. 1979
- Meiotic analysis of a pericentric inversion, inv(7) (p22q32), in the father of a child with a duplication-deletion of chromosome 7. Cytogenetic and Genome Research. 20:169-184. 1978
- Motor Vehicle Mortality Reductions since the Energy Crisis. Journal of Risk and Insurance. 44:373-373. 1977
- SYNCHRONOUS DIAPHRAGMATIC FLUTTER IN HORSES. Veterinary Record. 99:403-403. 1976
- TAPER OF INLAY AND CROWN PREPARATIONS. British Dental Journal. 140:82-82. 1976
- Role of pemetrexed in advanced non-small-cell lung cancer: meta-analysis of randomized controlled trials, with histology subgroup analysis. Current Oncology. 19:9-15.
other
- MONITORING THE STANDARD OF DEPUTIZING SERVICES. British Journal of General Practice. 390-392. 1993
preprints
- Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected Locally Advanced Non-Small Cell Lung Cancer treated with chemo- radiotherapy. 2024